The European Infusion Therapy Device Market demonstrates resilience in the face of economic uncertainties across the continent. Despite an impending recession, the market continues to grow steadily, driven by strong market drivers. In our blog, we delve into the factors propelling this growth, providing valuable insights on how businesses can leverage these drivers for success. Discover the untapped potential of the European Infusion Therapy Device Market and unlock growth opportunities in this ever-evolving landscape.
Demographic Factors
The rising elderly population in Europe serves as a key market driver, fueling demand for infusion therapy devices. With the elderly often requiring frequent and chronic treatments, the need for these devices is anticipated to surge. This, in turn, is expected to drive growth in both the disposable and capital equipment markets, with an increase in unit sales projected for the forecast period. The growing demand for infusion therapy devices in chronic treatment settings highlights the expanding market potential.
Adoption of Needleless Connectors
European countries have shown a remarkable inclination towards the rapid adoption of needleless connectors in the market over the past five years. This growing interest is fueled by the numerous advantages they offer. Needleless connectors play a crucial role in enhancing patient safety by reducing the risk of needlestick injuries and associated infections. Moreover, they provide convenience and efficiency by enabling easier access and administration of medications, minimizing the need for multiple needle insertions. These compelling benefits have resulted in the widespread adoption of needleless connectors throughout Europe.
Alternate Care
The utilization of alternate care settings, including home care, is progressively gaining prominence, accounting for a larger share of the total market compared to acute care. Prices for devices in alternate care sites tend to be higher due to the absence of bulk buys or Group Purchasing Organizations (GPOs) typically involved in hospitals and larger clinics. As the number of patients treated in alternate care settings is projected to rise at a faster pace than hospitalizations, this trend exerts upward pressure on the overall market’s average selling price (ASP). Consequently, the ASP of infusion therapy devices is expected to stabilize, resulting in a steady overall market growth.
Conclusion
In conclusion, the European Infusion Therapy Device Market proves its resilience in the face of economic uncertainties, offering growth opportunities for businesses. Demographic factors, particularly the rising elderly population requiring frequent treatments, drive demand and fuel market expansion. The rapid adoption of needleless connectors further enhances patient safety and convenience, leading to widespread implementation across European countries. Additionally, the prominence of alternate care settings, including home care, signifies a shift in the market landscape, with potential for increased ASP due to higher prices in these settings. Despite an impending recession, the market demonstrates stability and steady growth, presenting businesses with untapped potential and avenues for success in this dynamic industry.
For further information about the European Infusion therapy Device Market including Average Selling Prices (ASPs), Market Trends, Market Shares and more. Please feel free to request a complimentary sample of our 2023 report below:
